Pharmaco-invasive strategy with half-dose recombinant human prourokinase (PHDP): One-year outcomes

Pharmaco-invasive strategy with half-dose recombinant human prourokinase (PHDP): One-year outcomes

Bibliographic Details
Main Authors:	Chao Jiang, Jie Dou, Yun-Fei Ji, Dong-Lei Luo
Format:	Article
Language:	English
Published:	Elsevier 2023-06-01
Series:	Asian Journal of Surgery
Subjects:	Recombinant human prourokinase Primary percutaneous coronary intervention Follow up
Online Access:	http://www.sciencedirect.com/science/article/pii/S1015958423000398

Similar Items

Treatment of intravenous thrombolysis with half-dose recombinant human prourokinase reduces the rate of tirofiban use during early routine catheterization period
by: Chao Jiang, et al.
Published: (2022-07-01)

Effect of pharmaco-invasive strategy with half-dose recombinant human prourokinase on cardiac arrhythmias within 30 Days after percutaneous coronary intervention
by: Chao Jiang, et al.
Published: (2023-06-01)

Efficacy of half-dose recombinant human prourokinase thrombolysis combined with early PCI in 48 patients with ST-segment-elevation myocardial infarction (STEMI)
by: Jie Gao, et al.
Published: (2023-04-01)

Effect of pharmacoinvasive therapy with half-dose prourokinase on adverse cardiovascular events during angiography or percutaneous coronary intervention
by: Chao Jiang, et al.
Published: (2022-03-01)

Association between pharmaco-invasive strategy and serious procedure-related complications: A secondary analysis of the parmacoinvasive strategy with half-dose recombinant human prourokinase (PHDP) study
by: Chao Jiang, et al.
Published: (2023-07-01)

Efficacy and safety of intracoronary prourokinase during percutaneous coronary intervention in treating ST-segment elevation myocardial infarction patients: a randomized, controlled study
by: Yanqiang Wu, et al.
Published: (2020-06-01)

Use of health services and perceived need for information and follow-up after percutaneous coronary intervention
by: Nina Hjertvikrem, et al.
Published: (2024-01-01)

Does anxiety cause angina recurrence after percutaneous coronary intervention in patients with STEMI?
by: Zhipeng Zhang, et al.
Published: (2023-10-01)

A comparative study of pharmacokinetics of recombinant prourokinasein subconjunctival and drip methods of administration
by: E. V. Boyko, et al.
Published: (2018-10-01)

Efficacy and Safety of a Pharmaco-Invasive Strategy Using Half-Dose Recombinant Human Prourokinase in Patients with ST-Segment Elevation Myocardial Infarction During Hospitalization
by: Jie Dou MS, et al.
Published: (2024-01-01)

The surgical treatment of massive submacular hemorrhages aggravating the course of exudative form of AMD with automated subretinal injection
by: A. D. Ovchinnikova, et al.
Published: (2021-01-01)

The analysis of the lipid levels in patients with coronary artery disease after percutaneous coronary intervention: a one-year follow-up observational study
by: Weiyu Qiu, et al.
Published: (2020-07-01)

Pharmaco‐Invasive Strategy: The Answer to Improving ST‐Elevation–Myocardial Infarction Care
by: Amgad Mentias, et al.
Published: (2020-06-01)

Development and Validation of a Prediction Rule for Major Adverse Cardiac and Cerebrovascular Events in High-Risk Myocardial Infarction Patients After Primary Percutaneous Coronary Intervention
by: Zhao X, et al.
Published: (2022-07-01)

Pharmaco-invasive Approach to Acute Coronary Syndrome with Acute Thrombotic Occlusion: A Tough Enemy to Conquer
by: Rutvik Trivedi
Published: (2020-06-01)

CLINICAL OUTCOMES OF PERCUTANEOUS CORONARY INTERVENTION WITH DRUG ELUTING STENT IN STABLE ANGINA PATIENTS
by: D. I. Tomilova, et al.
Published: (2017-10-01)

ST‐Segment–Elevation Myocardial Infarction Care in America: Celebration and Anxiety
by: Kirk N. Garratt
Published: (2020-06-01)

Post-discharge and long-term follow-up after an acute coronary syndrome: International Collaborative Group of CNCF position paper.
by: Pierre Sabouret, et al.
Published: (2022-06-01)

Scoring System for Identification of “Survival Advantage” after Successful Percutaneous Coronary Intervention in Patients with Chronic Total Occlusion
by: Tatsuya Nakachi, et al.
Published: (2020-05-01)

Short-term outcomes of left main coronary artery disease treatment: A comparative study of optimal medical therapy, coronary artery bypass grafting, and percutaneous coronary intervention
by: Pravesh Vishwakarma, et al.
Published: (2020-01-01)

The Impact of Advanced Age on Major Cardiovascular Events and Mortality in Patients with ST-Elevation Myocardial Infarction Undergoing a Pharmaco-Invasive Strategy
by: Helber I, et al.
Published: (2020-05-01)

Long-term follow-up of patients with chronic total coronary artery occlusion previously randomized to treatment with optimal drug therapy or percutaneous revascularization of chronic total occlusion (COMET-CTO)
by: Stefan A. Juricic, et al.
Published: (2023-01-01)

Clinical characteristics, procedural details, and outcomes of patients who underwent percutaneous coronary intervention in real-world practice at a tertiary care center in Sri Lanka
by: Faslur Rahuman, et al.
Published: (2023-01-01)

Major adverse cardiovascular event (MACE) after percutaneous coronary intervention in one-year follow-up study
by: Hossein Farshidi, et al.
Published: (2018-02-01)

Reperfusion Strategy of ST-Elevation Myocardial Infarction: A Meta-Analysis of Primary Percutaneous Coronary Intervention and Pharmaco-Invasive Therapy
by: Kaiyin Li, et al.
Published: (2022-03-01)

One-Year Follow-Up Evaluation of Cognitive Function in Patients with Coronary Artery Disease and Over 65 Years of Age in Isfahan City, Iran
by: Majid Barekatain, et al.
Published: (2017-10-01)

In-hospital Outcomes in Patients Undergoing Percutaneous Coronary Intervention in Peri-urban Area Hospital Without Cardiac Surgery Backup
by: Manoj Shrestha, et al.
Published: (2021-12-01)

CONQUEST Quality Standards: For the Collaboration on Quality Improvement Initiative for Achieving Excellence in Standards of COPD Care
by: Pullen R, et al.
Published: (2021-08-01)

Does Anxiety Affect Survival in Patients with Coronary Heart Disease?
by: Hans-Christian Deter, et al.
Published: (2023-03-01)

Comparison of the New Multiepitope Recombinant Peptide Antigen with Cyst Fluid Antigen in the Follow-up of Patients with Cystic Echinococcosis
by: Eylem Akdur Öztürk, et al.
Published: (2021-09-01)

Angiographic predictors of success in antegrade approach of Chronic Total Occlusion interventions in a South Indian population in the contemporary era
by: Gopakumar KS, et al.
Published: (2018-01-01)

Diabetic kidney disease as an independent predictor of long-term adverse outcomes in patients with coronary artery disease and diabetic mellitus
by: Zhiyu Liu, et al.
Published: (2024-03-01)

Contrast Induced Nephropathy
by: Nurul R Ningrum, et al.
Published: (2013-06-01)

Pre-procedural serum lipid profile and post-procedural myocardial injury
by: Hamidreza Sanati
Published: (2013-01-01)

The Effect of Periprocedural Clinical Factors Related to the Course of STEMI in Men and Women Based on the National Registry of Invasive Cardiology Procedures (ORPKI) between 2014 and 2019
by: Janusz Sielski, et al.
Published: (2021-12-01)

Outcomes of supraflex sirolimus eluting coronary stents
by: Vishal Virendra Singh, et al.
Published: (2022-01-01)

Outcomes of supraflex Sirolimus-eluting coronary stents
by: Vishal Virendra Singh, et al.
Published: (2022-01-01)

Impact of percutaneous coronary intervention on renal function in patients with coronary heart disease
by: Bing Ji, et al.
Published: (2023-11-01)

Broken coronary stent catheter retrieval percutaneously case report and literature review
by: Evliya Akdeniz, et al.
Published: (2019-01-01)

Early Outcome of Bifurcational Coronary Artery Stenting
by: Ahmed Y. Bedair, et al.
Published: (2011-06-01)